Cytokinetics | CYTK - Ebitda

Prezzo Delle Azioni
65.01
Cambio Giornaliero
0.42 0.65%
Mensile
2.17%
Annuale
68.20%
Q2 Previsione
63.24




Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Amgen USD 5.14B 775M 2025-12
Arca Biopharma USD -25.07M 5.23M 2025-03
Bayer EUR 1.97B 457M 2025-12
Biogen USD 573.2M 253.7M 2025-12
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Capricor Therapeutics USD -27.23M 2.66M 2025-06
Cytokinetics USD -277.18M 169.36M 2025-09
Eisai JPY 30.1B 6.62B 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Exelixis USD 248.93M 28.02M 2025-09
Geron USD -9.47M 1.92M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Ligand Pharmaceuticals USD 150.32M 129.42M 2025-09
Merck USD 8.39B 1.97B 2025-09
Novartis USD 4.77B 1.11B 2025-12
Pfizer USD 6.08B 351M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09